Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi
- PMID: 8000341
Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi
Abstract
T cell responses to lipophosphoglycan-associated protein (LPG-AP) and the rgp63 antigens were studied in subjects with either asymptomatic L. chagasi infection or cured visceral leishmaniasis. The [3H]-thymidine uptake of lymphocytes stimulated with LPG-AP and rgp63 (mean +/- SD) was 14275 +/- 5048 and 3523 +/- 1678 cpm, respectively, for subjects with asymptomatic L. chagasi infection and 20046 +/- 5102 and 5086 +/- 3500 cpm, respectively, for subjects cured of visceral leishmaniasis. The responses to LPG-AP in both asymptomatic and cured visceral leishmaniasis were higher (P < 0.01) than those observed with rpg63. LPG-AP induced IFN-gamma production in all subjects studied, while rgp63 did not induce lymphocyte proliferation or IFN-gamma production in the majority of the subjects tested. IFN-gamma levels in cultures stimulated with LPG-AP were 103 +/- 81 pg/ml in individuals with asymptomatic L. chagasi infection and 127 +/- 123 pg/ml in subjects cured of visceral leishmaniasis. IFN-gamma levels in cultures stimulated with LPG-AP from subjects with asymptomatic L. chagasi infection were comparable to those observed in subjects cured of visceral leishmaniasis (P > 0.05). These data indicate that LPG-AP is recognized and induces T cell proliferation and IFN-gamma production in subjects with protective immune response against Leishmania chagasi.
Similar articles
-
[Protective effects of leishmanial antigens against Leishmania infantum infection in Lagurus lagurus].Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1999;17(4):237-40. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1999. PMID: 12563775 Chinese.
-
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.Vaccine. 2007 May 22;25(21):4223-34. doi: 10.1016/j.vaccine.2007.02.083. Epub 2007 Mar 15. Vaccine. 2007. PMID: 17395339 Clinical Trial.
-
Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.Clin Exp Immunol. 1994 Jun;96(3):416-21. doi: 10.1111/j.1365-2249.1994.tb06044.x. Clin Exp Immunol. 1994. PMID: 8004810 Free PMC article.
-
[Mediterranean visceral leishmaniasis: physiopathology].Presse Med. 1999 Jan 9;28(1):33-9. Presse Med. 1999. PMID: 9951509 Review. French.
-
T-cell response in human leishmaniasis.Immunol Lett. 1999 Jan;65(1-2):105-8. doi: 10.1016/s0165-2478(98)00132-1. Immunol Lett. 1999. PMID: 10065635 Review.
Cited by
-
In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.Clin Exp Immunol. 2006 Feb;143(2):338-44. doi: 10.1111/j.1365-2249.2006.02995.x. Clin Exp Immunol. 2006. PMID: 16412059 Free PMC article.
-
Further evidences on a new diagnostic approach for monitoring human Leishmania (L.) infantum chagasi infection in Amazonian Brazil.Parasitol Res. 2010 Jan;106(2):377-86. doi: 10.1007/s00436-009-1672-x. Epub 2009 Nov 28. Parasitol Res. 2010. PMID: 19946708
-
Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. major.Infect Immun. 2004 Aug;72(8):4486-93. doi: 10.1128/IAI.72.8.4486-4493.2004. Infect Immun. 2004. PMID: 15271907 Free PMC article.
-
Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy.Front Immunol. 2024 Nov 25;15:1448489. doi: 10.3389/fimmu.2024.1448489. eCollection 2024. Front Immunol. 2024. PMID: 39654897 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources